1ЭХЭМҮТ, 2Монголын эх барих, эмэгтэйчүүдийн эмч нарын нийгэмлэг
Background: Last two decades the UNFPA was played active role in reproductive health issues in Mongolia. Assessment of the Reproductive Health Commodity Security project was followed outline of the Monitoring and Evaluation Framework at country level. The current report was followed fifth evaluation survey in 2013, with technical and financial supports from the UNPFA. This paper presents the availability of essential life saving maternal/reproductive medicines incldung 7 life-saving maternal/RH medicines from UNFPA list in selected service delivery points.
Objectives: To assess availability of 7 life-saving maternal/RH medicines from UNFPA list of priority medicines in Mongolia.
Methods: The study followed cross sectional, descriptive study design. Data collection was conducted among SDPs that provide Maternal/Reproductive Health medicines in Mongolia. Initially list of all SDPs that provide family planning and maternal health services in each of the aimags and districts of Ulaanbaatar was obtained from the Ministry of Health and City Health Department. A total of 176 SDPs comprised of government and NGO were randomly selected from all regions of the country. Data was collected and recorded by trained study team with ability to accurately make observations. The questionnaire was coded and Epidata 2.0 was used for double data entry. Finally the data was exported to Stata programme for analysis.
Results: Most of the SDPs were equipped with the essential two medicines namely magnesium sulphate (97.6%) and oxytocine (96.4%). For the antibiotics, amoxicillin (96.2%), gentamycin (92.9%) and metronidazole (86.9%) were well equipped by the facilities. However, some medicines such as azithriomycine (31.0%), hydralazine (31.0%), misoprostol (40.5%), mifepristone (19.1%) were less available at the SDPs.
Availability of seven essential life-saving maternal and RH medicines was highest in tertiary level facilities (100.0%) at the time of the survey. On the other hand, 86.3% of primary health facilities and 92.6% of secondary level facilities available in stock at the time of the survey. Availability of maternal/reproductive health medicines at service delivery points is influenced by factors such as type of health facility, the region in which the service delivery is located, urban-rural residence, and distance.
Conclusion: Even though the overall findings of the survey showed that there has been successful achievement in availability of maternal/reproductive health medicines at all levels of SDPs in Mongolia, in order to coordinate sustainable supply of these medicines a multi- sectorial approach is crucial. Thus logistics system should be strengthened to coordinate sustainable supply of essential life-saving maternal and RH medicines to all levels of SDPs.
